Author Archive
Published by Fedra Pavlou, PharmTech Europe on December 3, 2010
under Trends
We all know that the popularity of social media has sky rocketed, for the pharma industry, most notably within the last 12 months. Testament to this increase is the popularity of this blog, as well our LinkedIn group. I am proud to say that we now have 1,200 members of this group (and counting!) so it’s clear that people enjoy “meeting” and sharing ideas in this way. Don’t get me wrong, we’re still testing the water; trying to work out how best to use this new tool. Read more »
Published by Fedra Pavlou, PharmTech Europe on October 8, 2010
under Europe News, Industry conferences, Ingredients
So I’ve just returned from an exhausting but a fantastic week in Paris. The beautiful French capital played host to this year’s CPhI exhibition and whilst I didn’t get to take advantage of the cultural and architectural wonders that the city has to offer, I have to say that I came away with a real feeling of optimism (accompanied by a pair of very sore feet of course). Read more »
Published by Fedra Pavlou, PharmTech Europe on February 3, 2010
under Drug Delivery, Industry conferences, Packaging & Labeling
I have just returned from an event in France which, I have to say, really impressed me. Not because I had the perfect excuse to visit Paris for a couple of days (although that was undoubtedly a bonus), but because I was so impressed by the calibre of presentations and new innovations that were showcased from this relatively small meeting. Read more »
Published by Fedra Pavlou, PharmTech Europe on November 4, 2009
under Europe News, Products, Regulation
In a news release issued by the European Organisation for Rare Diseases (EURORDIS) this week, the society commended the European Medicines Agency (EMEA) in its efforts to make the information that it has available on medicines more patient-friendly. Read more »
Published by Fedra Pavlou, PharmTech Europe on July 14, 2009
under Trends
Resistance to the social networking revolution has been particularly high amongst pharmaceutical industry professionals, though now it seems that more and more are coming round to the idea. Interestingly, it’s not only the pharma elite that are jumping on the bandwagon; so too are government agencies and, most notably, the FDA. Read more »
Published by Fedra Pavlou, PharmTech Europe on May 13, 2009
under Europe News, Industry conferences, Manufacturing
Thousands of people, enormous halls separated by mile-long walkways, huge machines promising to deliver efficient, cost-effective solutions, dancing jumpsuit wearers, superheroes, robots, and one pair of very sore feet. This is my first experience of Achema. Read more »
